Andrew John Partridge

Insider Reports History

Entity
Individual
Location
C/O Centrexion Therapeutics Corporation, 200 State Street, Boston, Massachusetts
Signature
/s/ Paolo Tombesi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew John Partridge:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Turning Point Therapeutics, Inc. EVP & Chief Commercial Officer Common Stock 38,361 $2.92 M $76.00 Feb 9, 2022 Direct
Turning Point Therapeutics, Inc. EVP & Chief Commercial Officer Stock Option (right to buy) 58,600 Feb 9, 2022 Direct

Insider Reports Filed by Andrew John Partridge

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TPTX Turning Point Therapeutics, Inc. Feb 9, 2022 3 -8,022 4 Feb 11, 2022 EVP & Chief Commercial Officer
TPTX Turning Point Therapeutics, Inc. Jul 14, 2021 1 -139,988 4 Jul 15, 2021 EVP & Chief Commercial Officer